TAK1 is a ubiquitin-dependent kinase of MKK and IKK
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
TRAF6 is a signal transducer that activates IkappaB kinase (IKK) and Jun amino-terminal kinase (JNK) in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and lipopolysaccharides (LPS). IKK activation by TRAF6 requires two intermediary factors, TRAF6-regulated IKK activator 1 (TRIKA1) and TRIKA2 (ref. 5). TRIKA1 is a dimeric ubiquitin-conjugating enzyme complex composed of Ubc13 and Uev1A (or the functionally equivalent Mms2). This Ubc complex, together with TRAF6, catalyses the formation of a Lys 63 (K63)-linked polyubiquitin chain that mediates IKK activation through a unique proteasome-independent mechanism. Here we report the purification and identification of TRIKA2, which is composed of TAK1, TAB1 and TAB2, a protein kinase complex previously implicated in IKK activation through an unknown mechanism. We find that the TAK1 kinase complex phosphorylates and activates IKK in a manner that depends on TRAF6 and Ubc13-Uev1A. Moreover, the activity of TAK1 to phosphorylate MKK6, which activates the JNK-p38 kinase pathway, is directly regulated by K63-linked polyubiquitination. We also provide evidence that TRAF6 is conjugated by the K63 polyubiquitin chains. These results indicate that ubiquitination has an important regulatory role in stress response pathways, including those of IKK and JNK.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Meanwhile, knockdown of TAB1 was previously shown not to impact IKK activation (Chen, 2005; Wang et al., 2001), consistent with our finding that TAB1 was not detected as a hit in any cell line.”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Wang et al., 2001
Citations
Cites
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Mann, M., Manning, A., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,040
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Self-citationTRAF6 is a signal transducer for interleukin-1
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,303
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
Malinin, N. L., Boldin, M. P., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,280
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
Self-citationSite-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity
Chen, Z. J., Parent, L., & Maniatis, T. (1996) · Cell · doi:10.1016/s0092-8674(00)81064-8 · Cited by 951
Self-citation
Cited by
Items 401–500 of 1,008
Gehrke, N., Hövelmeyer, N., Waisman, A., Straub, B. K., Weinmann-Menke, J., Wörns, M. A., Galle, P. R., & Schattenberg, J. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.008 · Cited by 162
Toll-Like Receptor Polymorphisms, Inflammatory and Infectious Diseases, Allergies, and Cancer
Medvedev, A. E. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0140 · Cited by 162
A Novel Type of Deubiquitinating Enzyme
Evans, P. C., Smith, T. S., Lai, M.-J., Williams, M. G., Burke, D. F., Heyninck, K., Kreike, M. M., Beyaert, R., Blundell, T. L., & Kilshaw, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301863200 · Cited by 161
Modulation of Toll?interleukin 1 receptor mediated signaling
Li, X., & Qin, J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0622-4 · Cited by 161
Bacterial recognition and signalling by the Drosophila IMD pathway
Kaneko, T., & Silverman, N. S. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00504.x · Cited by 161
Frobøse, H., Groth Rønn, S., Heding, P. E., Mendoza, H., Cohen, P., Mandrup-Poulsen, T., & Billestrup, N. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0301 · Cited by 160
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
Ahmed, N., Zeng, M., Sinha, I., Polin, L., Wei, W.-Z., Rathinam, C., Flavell, R., Massoumi, R., & Venuprasad, K. (2011) · Nature Immunology · doi:10.1038/ni.2157 · Cited by 160
Polyubiquitin binding to ABIN1 is required to prevent autoimmunity
Nanda, S. K., Venigalla, R. K. C., Ordureau, A., Patterson-Kane, J. C., Powell, D. W., Toth, R., C. Arthur, J. S., & Cohen, P. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102177 · Cited by 160
Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis
Groves, J. A., Lee, A., Yildirir, G., & Zachara, N. E. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0426-y · Cited by 160
TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils
Alagbala Ajibade, A., Wang, Q., Cui, J., Zou, J., Xia, X., Wang, M., Tong, Y., Hui, W., Liu, D., Su, B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.010 · Cited by 159
Regulation of death receptor signaling by the ubiquitin system
Wertz, I. E., & Dixit, V. M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.168 · Cited by 159
Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-α signaling
Polekhina, G., House, C. M., Traficante, N., Mackay, J. P., Relaix, F., Sassoon, D. A., Parker, M. W., & Bowtell, D. D. L. (2001) · Nature Structural Biology · doi:10.1038/nsb743 · Cited by 159
Role of Type 2C Protein Phosphatases in Growth Regulation and in Cellular Stress Signaling
Lammers, T., & Lavi, S. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701693342 · Cited by 158
Degradation of Activated Protein Kinases by Ubiquitination
Zhi-min, L., & Tony, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.013008.092711 · Cited by 158
TRAF‐Mediated TNFR‐Family Signaling
Arron, J. R., Walsh, M. C., & Choi, Y. (2002) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds51 · Cited by 157
Arsura, M., Panta, G. R., Bilyeu, J. D., Cavin, L. G., Sovak, M. A., Oliver, A. A., Factor, V. M., Heuchel, R. L., Mercurio, F., Thorgeirsson, S. S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206132 · Cited by 157
Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity
Hegde, A. N. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.005 · Cited by 157
Below the surface: The inner lives of TLR4 and TLR9
Marongiu, L., Gornati, L., Artuso, I., Zanoni, I., & Granucci, F. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1218-483rr · Cited by 156
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Sekhar, K. R., Yan, X. X., & Freeman, M. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205905 · Cited by 156
Essential role of TAK1 in thymocyte development and activation
Liu, H.-H., Xie, M., Schneider, M. D., & Chen, Z. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603089103 · Cited by 155
Self-citationSchilling, J. D., Martin, S. M., Hunstad, D. A., Patel, K. P., Mulvey, M. A., Justice, S. S., Lorenz, R. G., & Hultgren, S. J. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1470-1480.2003 · Cited by 155
Ubiquitin-Proteasome System and Proteasome Inhibition: New Strategies in Stroke Therapy
Wójcik, C., & Napoli, M. D. (2004) · Stroke · doi:10.1161/01.str.0000126891.93919.4e · Cited by 155
NF-kB action in sepsis: the innate immune system and the heart
Maria, A. (2004) · Frontiers in bioscience · doi:10.2741/1304 · Cited by 155
TRAF‐Mediated TNFR‐Family Signaling
Ha, H., Han, D., & Choi, Y. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds87 · Cited by 154
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
Melisi, D., Xia, Q., Paradiso, G., Ling, J., Moccia, T., Carbone, C., Budillon, A., Abbruzzese, J. L., & Chiao, P. J. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr243 · Cited by 154
XIAP deficiency syndrome in humans
Latour, S., & Aguilar, C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.01.015 · Cited by 154
Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
Luftig, M. A., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E. D., Inoue, J., Nakano, H., Mak, T. W., Yeh, W., Li, X., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136756100 · Cited by 154
Self-citationMyD88 as a Bottle Neck in Toll/IL-1 Signaling
Takeuchi, O., & Akira, S. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59430-4_10 · Cited by 154
Adaptor usage and Toll‐like receptor signaling specificity
Dunne, A., & O‧Neill, L. A. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.024 · Cited by 153
Interaction between TAK1–TAB1–TAB2 and RCAN1–calcineurin defines a signalling nodal control point
Liu, Q., Caldwell-Busby, J., & Molkentin, J. D. (2009) · Nature Cell Biology · doi:10.1038/ncb1823 · Cited by 153
Reactive oxygen species induce Cox‐2 expression via TAK1 activation in synovial fibroblast cells
Onodera, Y., Teramura, T., Takehara, T., Shigi, K., & Fukuda, K. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.06.001 · Cited by 153
Regulation of innate immune signaling by IRAK proteins
Pereira, M. C. A., & Gazzinelli, R. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133354 · Cited by 152
Role of the ubiquitin proteasome system in Parkinson's disease
Lim, K.-L., & Tan, J. M. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s13 · Cited by 151
The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling
Moynagh, P. N. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.10.001 · Cited by 151
Sato, Y., Yoshikawa, A., Yamashita, M., Yamagata, A., & Fukai, S. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.345 · Cited by 151
Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression
Jeong, W., Bae, S. H., Tolédano, M. B., & Rhee, S. G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.020 · Cited by 150
Overexpression of Tropomysin-Related Kinase B in Metastatic Human Pancreatic Cancer Cells
Sclabas, G. M., Fujioka, S., Schmidt, C., Li, Z., Frederick, W., Yang, W., Yokoi, K., Evans, D. B., Abbruzzese, J. L., Hess, K. R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.440.11.2 · Cited by 150
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W., Zhang, M., & Sun, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 149
Hostager, B. S., Haxhinasto, S. A., Rowland, S. L., & Bishop, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306708200 · Cited by 149
Chen, H., Wu, Y., Zhang, Y., Jin, L., Luo, L., Xue, B., Lu, C., Zhang, X., & Yin, Z. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.066 · Cited by 148
CD40 and its viral mimic, LMP1: similar means to different ends
Lam, N., & Sugden, B. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00083-9 · Cited by 148
Kelsall, I. R., Zhang, J., Knebel, A., Arthur, J. S. C., & Cohen, P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905873116 · Cited by 147
Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity
Sato, Y., Gotō, E., Shibata, Y., Kubota, Y., Yamagata, A., Goto‐Ito, S., Kubota, K., Inoue, J., Takekawa, M., Tokunaga, F., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2970 · Cited by 147
Self-citationToll-Like Receptor 9 Agonists in Cancer
Karapetyan, L., Luke, J. J., & Davar, D. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247050 · Cited by 147
Branching Out: Improved Signaling by Heterotypic Ubiquitin Chains
Haakonsen, D. L., & Rape, M. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.06.003 · Cited by 146
Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signaling pathways
Shambharkar, P. B., Blonska, M., Pappu, B. P., Li, H., You, Y., Sakurai, H., Darnay, B. G., Hara, H., Penninger, J. M., & Lin, X. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601622 · Cited by 146
MAP kinase kinase kinases and innate immunity
Symons, A., Beinke, S., & Ley, S. C. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.11.007 · Cited by 145
Johnson, G. L., Dohlman, H. G., & Graves, L. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.04.004 · Cited by 145
TAK1-dependent Signaling Requires Functional Interaction with TAB2/TAB3
Besse, A., Lamothe, B., Campos, A. D., Webster, W. K., Maddineni, U., Lin, S.-C., Wu, H., & Darnay, B. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608867200 · Cited by 144
MicroRNAs in flow-dependent vascular remodelling
Neth, P., Nazari-Jahantigh, M., Schober, A., & Weber, C. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt096 · Cited by 144
Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation
Marwick, J. A., Mills, R., Kay, O., Michail, K., Stephen, J., Rossi, A. G., Dransfield, I., & Hirani, N. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0710-y · Cited by 144
Act1, a negative regulator in CD40- and BAFF-mediated B cell survival
Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E. C., Ware, C. F., Fairchild, R. L., Omori, S. A., Rickert, R. C., Scott, M., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.001 · Cited by 143
Canning, M., Boutell, C., Parkinson, J., & Everett, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402885200 · Cited by 143
Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathway
Guo, X., Harada, C., Namekata, K., Matsuzawa, A., Camps, M., Ji, H., Swinnen, D., Jorand‐Lebrun, C., Muzerelle, M., Vitte, P., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000103 · Cited by 143
Blonska, M., Shambharkar, P. B., Kobayashi, M., Zhang, D., Sakurai, H., Su, B., & Lin, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507807200 · Cited by 142
Schwabe, R. F., Uchinami, H., Qian, T., Bennett, B. L., Lemasters, J. J., & Brenner, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0771fje · Cited by 142
Pyroptosis-Induced Inflammation and Tissue Damage
Wei, Y., Yang, L., Pandeya, A., Cui, J., Zhang, Y., & Li, Z. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167301 · Cited by 142
NF-κB and the regulation of hematopoiesis
Bottero, V., Withoff, S., & Verma, I. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401888 · Cited by 142
Ali, S., & Mann, D. A. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1082 · Cited by 141
YopJ targets TRAF proteins to inhibit TLR-mediated NF-?B, MAPK and IRF3 signal transduction
Sweet, C. R., Conlon, J. E., Golenbock, D. T., Goguen, J. D., & Silverman, N. S. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00990.x · Cited by 139
Pan, J.-X., Ding, K., & Wang, C.-Y. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10290 · Cited by 138
Self-citationCanonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells
Kendellen, M. F., Bradford, J. W., Lawrence, C. L., Clark, K. S., & Baldwin, A. S. (2013) · Oncogene · doi:10.1038/onc.2013.64 · Cited by 138
Milivojevic, M., Dangeard, A., Kasper, C. A., Tschon, T., Emmenlauer, M., Pique, C., Schnupf, P., Guignot, J., & Arrieumerlou, C. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006224 · Cited by 138
Patinote, C., Karroum, N. B., Moarbess, G., Cirnat, N., Kassab, I., Bonnet, P., & Deleuze‐Masquéfa, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112238 · Cited by 138
Yang, J., Tseng, J., Yu, G., Luo, Y., Huang, C. F., Hong, Y., & Chuang, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020423 · Cited by 137
Konno, H., Yamamoto, T., Yamazaki, K., Gohda, J., Akiyama, T., Semba, K., Goto, H., Kato, A., Yujiri, T., Imai, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005674 · Cited by 137
Self-citationHarikumar, K. B., Yester, J., Surace, M. J., Oyeniran, C., Price, M. M., Huang, W., Hait, N. C., Allegood, J. C., Yamada, A., Kong, X., et al. (2014) · Nature Immunology · doi:10.1038/ni.2810 · Cited by 136
Clark, K., Takeuchi, O., Akira, S., & Cohen, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114194108 · Cited by 135
Kasper, C. A., Sorg, I., Schmutz, C., Tschon, T., Wischnewski, H., Kim, M. L., & Arrieumerlou, C. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.015 · Cited by 135
Windheim, M., Stafford, M., Peggie, M., & Cohen, P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02380-06 · Cited by 133
Marina-García, N., Franchi, L., Kim, Y.-G., Hu, Y., Smith, D. E., Boons, G.-J., & Núñez, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802197 · Cited by 133
Gesellchen, V., Kuttenkeuler, D., Steckel, M., Pelte, N., & Boutros, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400530 · Cited by 132
Lamothe, B., Campos, A. D., Webster, W. K., Gopinathan, A., Hur, L., & Darnay, B. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802749200 · Cited by 132
The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation
Hrdinka, M., & Gyrd‐Hansen, M. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.001 · Cited by 132
Modulating inflammation through the negative regulation of NF-κB signaling
Rothschild, D. E., McDaniel, D. K., Ringel-Scaia, V. M., & Allen, I. C. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0817-346rrr · Cited by 131
Toll-Like Receptor Signaling in Depression
Figueroa‐Hall, L. K., Paulus, M. P., & Savitz, J. B. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104843 · Cited by 131
Two Mechanistically and Temporally Distinct NF-κB Activation Pathways in IL-1 Signaling
Yamazaki, K., Gohda, J., Kanayama, A., Miyamoto, Y., Sakurai, H., Yamamoto, M., Akira, S., Hayashi, H., Su, B., & Inoue, J.-I. (2009) · Science Signaling · doi:10.1126/scisignal.2000387 · Cited by 130
Self-citationTGF-β1 Protects against Mesangial Cell Apoptosis via Induction of Autophagy
Ding, Y., Kim, J. K., Kim, S. I., Na, H.-J., Jun, S. Y., Lee, S. J., & Choi, M. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093724 · Cited by 130
GSK-3β controls NF-kappaB activity via IKKγ/NEMO
Medunjanin, S., Schleithoff, L.-M., Fiegehenn, C., Weinert, S., Zuschratter, W., & Braun-Dullaeus, R. C. (2016) · Scientific Reports · doi:10.1038/srep38553 · Cited by 130
Cytosolic Hsp60 Is Involved in the NF-κB-Dependent Survival of Cancer Cells via IKK Regulation
Chun, J. N., Choi, B., Lee, K. W., Lee, D. J., Kang, D. H., Lee, J. Y., Song, I. S., Kim, H. I., Lee, S. H., Kim, H. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009422 · Cited by 130
Wu, H.-T., Kuo, Y.-C., Hung, J.-J., Huang, C.-H., Chen, W.-Y., Chou, T.-Y., Chen, Y., Chen, Y.-J., Chen, Y.-J., Cheng, W.-C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13644 · Cited by 129
TIFA activates IκB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6
Ea, C.-K., Sun, L., Inoue, J.-I., & Chen, Z. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404132101 · Cited by 129
Self-citationAutophagy in regulation of Toll-like receptor signaling
Into, T., Inomata, M., Takayama, E., & Takigawa, T. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.020 · Cited by 129
Stress-induced O-GlcNAcylation: an adaptive process of injured cells
Martinez, M. R., Dias, T. B., NATOV, P. S., & Zachara, N. E. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160153 · Cited by 129
Luo, P., Wong, Y. F., Ge, L., Zhang, Z., Liu, Y., Liu, L., & Zhou, H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170852 · Cited by 129
A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways
Krappmann, D., & Scheidereit, C. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400380 · Cited by 128
“Both TRAF2 and TRAF6 activate c-Jun amino-terminal kinase (JNK) in parallel to IKK, in a process that also depends on the assembly of UbLys63 chains (Shi & Kehrl, 2003; Wang et al, 2001).”
BackgroundInfluentialTAB2 Is Essential for Prevention of Apoptosis in Fetal Liver but Not for Interleukin-1 Signaling
Sanjo, H., Takeda, K., Tsujimura, T., Ninomiya-Tsuji, J., Matsumoto, K., & Akira, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1231-1238.2003 · Cited by 128
Liu, X., Li, H., Zhong, B., Blonska, M., Gorjestani, S., Yan, M., Tian, Q., Zhang, D.-E., Lin, X., & Dong, C. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122327 · Cited by 128
The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways
Cohen, P., & Strickson, S. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.17 · Cited by 128
Nod2: A Critical Regulator of Ileal Microbiota and Crohn’s Disease
Sidiq, T., Yoshihama, S., Downs, I., & Kobayashi, K. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00367 · Cited by 127
Zhao, W., Wang, L., Zhang, M., Yuan, C., & Gao, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103255 · Cited by 127
Joh, E., Gu, W., & Kim, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.020 · Cited by 127
USP19 Inhibits TNF-α– and IL-1β–Triggered NF-κB Activation by Deubiquitinating TAK1
Lei, C., Wu, X., Zhong, X., Jiang, L., Zhong, B., & Shu, H. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900083 · Cited by 127
Yao, J., Kim, T. W., Qin, J., Jiang, Z., Qian, Y., Xiao, H. Q., Lu, Y., Wen, Q., Gulen, M. F., Sizemore, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609039200 · Cited by 127
A new look at T cell receptor signaling to nuclear factor-κB
Paul, S., & Schaefer, B. C. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.002 · Cited by 126
Molecular control of the NEMO family of ubiquitin-binding proteins
Clark, K., Nanda, S. K., & Cohen, P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3644 · Cited by 126
Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation
An, J., Mo, D., Liu, H., Veena, M. S., Srivatsan, E. S., Massoumi, R., & Rettig, M. B. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.007 · Cited by 126
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
DeSelm, C. J., Takahata, Y., Warren, J., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24165 · Cited by 125
Pal, S., Bhattacharjee, A., Ali, A., Mandal, N. C., Mandal, S. C., & Pal, M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-23 · Cited by 124
Metadata
- Authors
- Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- The University of Texas at Dallas (US)
- Keio University (JP)
- Corresponding author
- Chen, Zhijian J.
- Venue
- Nature
- Published
- 2001-07-19
- Volume
- 412
- Issue
- 6844
- Pages
- 346-351
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1600472471
- Cited by
- 2,125
- References
- 24
- Citations by year
- 2026: 49 · 2025: 59 · 2024: 62 · 2023: 66 · 2022: 68 · 2021: 74 · 2020: 92 · 2019: 76 · 2018: 96 · 2017: 92 · 2016: 85 · 2015: 66 · 2014: 96 · 2013: 96 · 2012: 119
- FWCI
- 31.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TAK1, TRAF6, IKK activation, MKK6, JNK, p38 MAPK, K63-linked ubiquitination, TAB1, TAB2, interleukin-1, lipopolysaccharide, inflammatory signaling, stress response
- MeSH terms
- MAP Kinase Kinase Kinase 7, Carrier Proteins, Cell Line, Cloning, Molecular, Enzyme Activation, HeLa Cells, Humans, Interleukin-1, Ligases, Multienzyme Complexes, Protein Kinases, Recombinant Proteins, Transcription Factors, Ubiquitins, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Mitogen-Activated Protein Kinase Kinases, MAP Kinase Kinase Kinases, MAP Kinase Signaling System, Ubiquitin-Conjugating Enzymes, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 6, MAP Kinase Kinase 4, Adaptor Proteins, Signal Transducing, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.